Kovitz Investment Group Partners’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.3M | Buy |
32,043
+23,574
| +278% | +$10.5M | 0.06% | 245 |
|
|
2025
Q1 | $4.11M | Sell |
8,469
-8,712
| -51% | -$4.22M | 0.02% | 437 |
|
|
2024
Q4 | $6.92M | Sell |
17,181
-18,902
| -52% | -$7.61M | 0.03% | 335 |
|
|
2024
Q3 | $15.4M | Buy |
36,083
+4,638
| +15% | +$1.98M | 0.11% | 167 |
|
|
2024
Q2 | $14.7M | Buy |
31,445
+29,843
| +1,863% | +$14M | 0.13% | 123 |
|
|
2024
Q1 | $670K | Buy |
+1,602
| New | +$670K | 0.01% | 461 |
|
|
2022
Q1 | – | Sell |
-3,128
| Closed | -$739K | – | 453 |
|
|
2021
Q4 | $739K | Sell |
3,128
-6,110
| -66% | -$1.44M | 0.02% | 308 |
|
|
2021
Q3 | $1.68M | Sell |
9,238
-2,420
| -21% | -$439K | 0.03% | 245 |
|
|
2021
Q2 | $2.35M | Buy |
11,658
+6,040
| +108% | +$1.22M | 0.05% | 223 |
|
|
2021
Q1 | $1.21M | Buy |
5,618
+2,490
| +80% | +$535K | 0.03% | 261 |
|
|
2020
Q4 | $739K | Sell |
3,128
-1,610
| -34% | -$380K | 0.02% | 304 |
|
|
2020
Q3 | $1.29M | Buy |
+4,738
| New | +$1.29M | 0.04% | 235 |
|